Literature DB >> 19887760

Central clock regulates the cervically stimulated prolactin surges by modulation of dopamine and vasoactive intestinal polypeptide release in ovariectomized rats.

Maristela O Poletini1, Jessica E Kennett, De'nise T McKee, Marc E Freeman.   

Abstract

BACKGROUND/AIMS: Cervical stimulation induces a circadian rhythm of prolactin secretion and antiphase dopamine release. The suprachiasmatic nucleus (SCN) controls this rhythm, and we propose that it does so through clock gene expression within the SCN.
METHODS: To test this hypothesis, serial blood samples were taken from animals injected with an antisense deoxyoligonucleotide cocktail for clock genes (generated against the 5' transcription start site and 3' cap site of per1, per2, and clock mRNA) or with a random-sequence deoxyoligonucleotide in the SCN. To determine whether disruption of clock genes in the SCN compromises the neural mechanism controlling prolactin secretion, we sacrificed another group of rats (under the same treatments) at 12.00 or 17.00 h. Dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) were measured using HPLC/electrochemical detection in the median eminence as well as the intermediate and the neural lobe of the pituitary gland, and the DOPAC:dopamine ratio was used as an index of dopamine activity. Vasoactive intestinal polypeptide (VIP) content was determined in tissue punches of the SCN and paraventricular nucleus (PVN), an SCN efferent.
RESULTS: Treatment with clock gene antisense deoxyoligonucleotide cocktail abolished both the diurnal and nocturnal prolactin surges induced by cervical stimulation. This treatment abolished the antiphase relationship established by cervical stimulation between dopamine neuronal activity and prolactin secretion. Also, VIP content increased in the SCN and decreased in the PVN.
CONCLUSION: These results suggest that the SCN clock determines the circadian rhythm of prolactin secretion in cervically stimulated rats by regulating dopamine neuronal activity and VIP inputs to the PVN. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887760      PMCID: PMC2853580          DOI: 10.1159/000254379

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  60 in total

1.  Suprachiasmatic efferents avoid phenestrated capillaries but innervate neuroendocrine cells, including those producing dopamine.

Authors:  T L Horvath
Journal:  Endocrinology       Date:  1997-03       Impact factor: 4.736

2.  The distribution of vasoactive intestinal peptide2 receptor messenger RNA in the rat brain and pituitary gland as assessed by in situ hybridization.

Authors:  W J Sheward; E M Lutz; A J Harmar
Journal:  Neuroscience       Date:  1995-07       Impact factor: 3.590

3.  A sex-specific endogenous stimulatory rhythm regulating prolactin secretion.

Authors:  B J Arey; R L Averill; M E Freeman
Journal:  Endocrinology       Date:  1989-01       Impact factor: 4.736

4.  Activity of oxytocinergic neurons in the paraventricular nucleus mirrors the periodicity of the endogenous stimulatory rhythm regulating prolactin secretion.

Authors:  B J Arey; M E Freeman
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

Review 5.  The mating-induced release of prolactin: a unique neuroendocrine response.

Authors:  J W Gunnet; M E Freeman
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

6.  Activity of vasoactive intestinal peptide and serotonin in the paraventricular nucleus reflects the periodicity of the endogenous stimulatory rhythm regulating prolactin secretion.

Authors:  B J Arey; M E Freeman
Journal:  Endocrinology       Date:  1992-08       Impact factor: 4.736

7.  Dopaminergic neurons of periventricular and arcuate nuclei of pseudopregnant rats: semicircadian rhythm in Fos-related antigens immunoreactivities and in dopamine concentration.

Authors:  A Lerant; M E Herman; M E Freeman
Journal:  Endocrinology       Date:  1996-09       Impact factor: 4.736

8.  Female reproductive function and sexually dimorphic prolactin secretion in rats with lesions in the medial preoptic-anterior hypothalamic continuum.

Authors:  M Jakubowski; J Terkel
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

9.  Circadian changes of serum prolactin levels and tuberoinfundibular dopaminergic neuron activities in ovariectomized rats treated with or without estrogen: the role of the suprachiasmatic nuclei.

Authors:  L M Mai; K R Shieh; J T Pan
Journal:  Neuroendocrinology       Date:  1994-11       Impact factor: 4.914

10.  Hypothalamic factors involved in the endogenous stimulatory rhythm regulating prolactin secretion.

Authors:  B J Arey; M E Freeman
Journal:  Endocrinology       Date:  1989-02       Impact factor: 4.736

View more
  5 in total

Review 1.  Neuroanatomy of the extended circadian rhythm system.

Authors:  Lawrence P Morin
Journal:  Exp Neurol       Date:  2012-07-02       Impact factor: 5.330

2.  Loss of BMAL1 in ovarian steroidogenic cells results in implantation failure in female mice.

Authors:  Yan Liu; Brian P Johnson; Anna L Shen; Jacqueline A Wallisser; Kathy J Krentz; Susan M Moran; Ruth Sullivan; Edward Glover; Albert F Parlow; Norman R Drinkwater; Linda A Schuler; Christopher A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-15       Impact factor: 11.205

3.  Circadian control of neuroendocrine circuits regulating female reproductive function.

Authors:  Wilbur P Williams; Lance J Kriegsfeld
Journal:  Front Endocrinol (Lausanne)       Date:  2012-05-21       Impact factor: 5.555

Review 4.  Circadian Tick-Talking Across the Neuroendocrine System and Suprachiasmatic Nuclei Circuits: The Enigmatic Communication Between the Molecular and Electrical Membrane Clocks.

Authors:  M D C Belle
Journal:  J Neuroendocrinol       Date:  2015-07       Impact factor: 3.627

Review 5.  Central circadian control of female reproductive function.

Authors:  Brooke H Miller; Joseph S Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2014-01-22       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.